Company performance
Add to research
Current Price
as of Feb 14, 2025$8.38
P/E Ratio
N/A
Market Cap
$51.04M
Description
Add to research
KALA BIO, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.
Metrics
Add to research
Overview
- HQArlington, MA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerKALA
- Price$8.38+7.99%
Trading Information
- Market cap$51.04M
- Float82.24%
- Average Daily Volume (1m)110,979
- Average Daily Volume (3m)60,313
- EPS-$12.47
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$8.95M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$9.50M
- EV$14.21M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B5.63
- Debt/Equity540.01
Documents
Add to research
SEC Filings
Factset Street Account